Adiponectin/(FBG × FIns) as a predictor of insulin sensitivity and metabolic syndrome in patients with polycystic ovary syndrome

The euglycemic–hyperinsulinemic clamp is not available in most clinical settings. An accessible and inexpensive measurement for identifying insulin resistance (IR) is necessary. Our aim is to assess whether the adiponectin (ADI) index (ADI/[FBG × FIns]) is a better surrogate index for the assessment...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xiaohui, Lai, Yerui, Yang, Gangyi, Yang, Mengliu, Li, Ling, Zhang, Qin, Liu, Hua, Zheng, Hongting, Zhu, Danping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266016/
https://www.ncbi.nlm.nih.gov/pubmed/27930544
http://dx.doi.org/10.1097/MD.0000000000005524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266016/
https://www.ncbi.nlm.nih.gov/pubmed/27930544
http://dx.doi.org/10.1097/MD.0000000000005524

Ejemplares similares